Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
Support MFO
Donate through PayPal
Grantham’s GMO: Stockpicking Isn’t Dead, It Just Smelled Funny Last Year
FYI: For many, the epitaph for stockpicking was written with 2014′s dismal performance.
Not so fast, say Neil Constable and Matt Kadnar at GMO, the $120 billion investment house co-founded by the legendary Jeremy Grantham. Constable, head of his firm’s global equity team, and Kadnar, an asset allocator, make the case this week that 2014 was a most unusual year and therefore ought not be the reason for investors to sour on active management, however tempting that might be. Regards, Ted http://blogs.barrons.com/focusonfunds/2015/02/12/granthams-gmo-stockpicking-isnt-dead-it-just-smelled-funny-last-year/tab/print/
